TIMP1 and lung carcinoma: Considering that cisplatin has been found to similarly induce TIMP-1 as part of its anti-invasive action on cervical and lung cancer cells [26], the present study addressed a probable TIMP-1-dependent antiangiogenic action of cisplatin at non-toxic concentrations.